688098 申联生物
2024/06 - 中期
人民币(K¥)
与去年末期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)

非流动资产
长期股权投资1,583-0.19%1,5861,5771,5711,571
投资性房地产0--0000
固定资产651,514-1.04%658,335677,239634,215550,602
在建工程156,525-4.23%163,44398,949133,77892,158
无形资产107,16914.50%93,59953,12132,66033,226
商誉0--0000
其他非流动资产70,021-11.08%78,74268,69462,77843,054
986,812-0.89%995,704899,580865,003720,610

流动资产
货币资金138,282207.46%44,97652,74344,213114,614
应收账款272,297-0.61%273,974222,153151,015131,311
存货114,2042.16%111,789115,329103,42171,172
其他流动资产45,578-72.80%167,552315,279434,813476,761
570,361-4.67%598,290705,504733,461793,859

流动负债
短期借款0--0000
应付票据0--0000
应付帐款3,504-31.88%5,1448,86011,3337,536
其他流动负债84,95419.05%71,35988,357102,19798,337
88,45815.63%76,50397,217113,529105,873
流动资产净值481,903-7.64%521,787608,287619,932687,986
资产总额减流动负债1,468,715-3.21%1,517,4911,507,8671,484,9351,408,596

非流动负债
长期借款0--0000
应付债券0--0000
其他非流动负债12,45519.50%10,42310,99611,94712,331
12,45519.50%10,42310,99611,94712,331

总权益
    实收股本410,6440.00%410,644410,644410,644409,700
    储备项目1,029,208-4.53%1,078,0881,086,2271,068,233986,713
股东权益1,439,852-3.28%1,488,7321,496,8711,478,8771,396,413
非控股权益16,408-10.51%18,3360(5,890)(147)